000 01229 a2200337 4500
005 20250518084759.0
264 0 _c20210125
008 202101s 0 0 eng d
022 _a2211-0356
024 7 _a10.1016/j.msard.2020.101978
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJeung, L
245 0 0 _aA tumefactive demyelinating lesion in a person with MS after five years of fingolimod.
_h[electronic resource]
260 _bMultiple sclerosis and related disorders
_cMay 2020
300 _a101978 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAdult
650 0 4 _aBrain
_xdiagnostic imaging
650 0 4 _aFingolimod Hydrochloride
_xadverse effects
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xadverse effects
650 0 4 _aMagnetic Resonance Imaging
650 0 4 _aMale
650 0 4 _aMultiple Sclerosis, Relapsing-Remitting
_xdrug therapy
700 1 _aSmits, L M G
700 1 _aHoogervorst, E L J
700 1 _avan Oosten, B W
700 1 _aFrequin, S T F M
773 0 _tMultiple sclerosis and related disorders
_gvol. 40
_gp. 101978
856 4 0 _uhttps://doi.org/10.1016/j.msard.2020.101978
_zAvailable from publisher's website
999 _c30638849
_d30638849